These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 21284557)

  • 21. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
    Sauer D; Zheng W; Coots LB; McGinity JW
    Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of process variables on physicomechanical properties of the agglomerates obtained by spherical crystallization technique.
    Maghsoodi M
    Pharm Dev Technol; 2011 Oct; 16(5):474-82. PubMed ID: 20557281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Formulation and evaluation of chitosan microspheres of aceclofenac for colon-targeted drug delivery.
    Umadevi SK; Thiruganesh R; Suresh S; Reddy KB
    Biopharm Drug Dispos; 2010 Oct; 31(7):407-27. PubMed ID: 20848388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physicomechanical properties of naproxen-loaded microparticles prepared from Eudragit l100.
    Maghsoodi M
    AAPS PharmSciTech; 2009; 10(1):120-8. PubMed ID: 19184624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation and optimization of PMAA-chitosan-PEG nanoparticles for oral drug delivery.
    Pawar H; Douroumis D; Boateng JS
    Colloids Surf B Biointerfaces; 2012 Feb; 90():102-8. PubMed ID: 22037474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preparation and evaluation of modified release ibuprofen microspheres with acrylic polymers (Eudragit) by quasi-emulsion solvent diffusion method: effect of variables.
    Devrim B; Canefe K
    Acta Pol Pharm; 2006; 63(6):521-34. PubMed ID: 17438870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lappaconitine-loaded microspheres for parenteral sustained release: effects of formulation variables and in vitro characterization.
    Xu H; Zhong H; Liu M; Xu C; Gao Y
    Pharmazie; 2011 Sep; 66(9):654-61. PubMed ID: 22026119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparation and characterization of drug-loaded polymethacrylate microspheres by an emulsion solvent evaporation method.
    Kim BK; Hwang SJ; Park JB; Park HJ
    J Microencapsul; 2002; 19(6):811-22. PubMed ID: 12569029
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymethacrylates as crystallization inhibitors in monolayer transdermal patches containing ibuprofen.
    Cilurzo F; Minghetti P; Casiraghi A; Tosi L; Pagani S; Montanari L
    Eur J Pharm Biopharm; 2005 May; 60(1):61-6. PubMed ID: 15848057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Eudragit matrices for sustained release of ketorolac tromethamine: formulation and kinetics of release.
    Ruckmani K; Muneera MS; Vijaya R
    Boll Chim Farm; 2000; 139(5):205-8. PubMed ID: 11213438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Floating hot-melt extruded tablets for gastroretentive controlled drug release system.
    Fukuda M; Peppas NA; McGinity JW
    J Control Release; 2006 Oct; 115(2):121-9. PubMed ID: 16959356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sustained-release of buspirone HCl by co spray-drying with aqueous polymeric dispersions.
    Al-Zoubi N; Alkhatib HS; Bustanji Y; Aiedeh K; Malamataris S
    Eur J Pharm Biopharm; 2008 Jun; 69(2):735-42. PubMed ID: 18291632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Properties of melt extruded enteric matrix pellets.
    Schilling SU; Shah NH; Waseem Malick A; McGinity JW
    Eur J Pharm Biopharm; 2010 Feb; 74(2):352-61. PubMed ID: 19782133
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Statistical optimization of indomethacin pellets coated with pH-dependent methacrylic polymers for possible colonic drug delivery.
    Akhgari A; Afrasiabi Garekani H; Sadeghi F; Azimaie M
    Int J Pharm; 2005 Nov; 305(1-2):22-30. PubMed ID: 16236475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Eudragit-S, Eudragit-L and cellulose acetate phthalate coated polysaccharide tablets for colonic targeted delivery of azathioprine.
    Kotagale N; Maniyar M; Somvanshi S; Umekar M; Patel CJ
    Pharm Dev Technol; 2010; 15(4):431-7. PubMed ID: 20236031
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diclofenac-loaded Eudragit S100 nanosuspension for ophthalmic delivery.
    Ahuja M; Dhake AS; Sharma SK; Majumdar DK
    J Microencapsul; 2011; 28(1):37-45. PubMed ID: 21171815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of encapsulation of mefenamic acid with cationic Eudragit E on its bioavailability and gastric ulcerogenic activity in rabbits.
    Ramadan EM; el-Helw A; el-Said Y
    J Microencapsul; 1987; 4(2):125-32. PubMed ID: 3504500
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability.
    Zhuang CY; Li N; Wang M; Zhang XN; Pan WS; Peng JJ; Pan YS; Tang X
    Int J Pharm; 2010 Jul; 394(1-2):179-85. PubMed ID: 20471464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel controlled release solid dispersion for the delivery of diclofenac sodium.
    Giri TK; Kumar K; Alexander A; Ajazuddin ; Badwaik H; Tripathy M; Tripathi DK
    Curr Drug Deliv; 2013 Aug; 10(4):435-43. PubMed ID: 23517623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of processing temperature on Eudragit RS PO microsphere characteristics in the solvent evaporation process.
    Sahoo SK; Dhal S; Mohapatro P; Behera BC; Barik BB
    Pharmazie; 2007 Aug; 62(8):638-9. PubMed ID: 17867564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.